Randomized phase II study of cisplatin and etoposide versus temozolomide and capecitabine in patients (pts) with advanced G3 non-small cell gastroenteropancreatic neuroendocrine carcinomas (GEPNEC): A trial of the ECOG-ACRIN Cancer Research Group (EA2142).

被引：5
|
作者：
Eads, Jennifer Rachel
Catalano, Paul J.
Fisher, George A.
Klimstra, David S.
Zhang, Zheng
Rubin, Daniel
Iagaru, Andrei
Wong, Terence Z.
O'Dwyer, Peter J.
机构：
[1] Case Western Reserve Univ, Univ Hosp, Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Stanford Univ, Stanford, CA 94305 USA
[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[5] Brown Univ, Providence, RI 02912 USA
[6] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[7] Univ N Carolina, Chapel Hill, NC USA
[8] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.TPS4149
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4149
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Randomized phase II study of platinum and etoposide (EP) versus temozolomide and capecitabine (CAPTEM) in patients (pts) with advanced G3 non-small cell gastroenteropancreatic neuroendocrine neoplasms (GEPNENs): ECOG-ACRIN EA2142.
    Eads, Jennifer Rachel
    Catalano, Paul J.
    Fisher, George A.
    Rubin, Daniel
    Iagaru, Andrei
    Klimstra, David S.
    Konda, Bhavana
    Kwong, Myron S.
    Chan, Jennifer A.
    De Jesus-Acosta, Ana
    Halfdanarson, Thorvardur Ragnar
    Shaib, Walid Labib
    Soares, Heloisa P.
    Hong, Sung Chul
    Wong, Terence Z.
    O'Dwyer, Peter J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211).
    Kunz, Pamela L.
    Catalano, Paul J.
    Nimeiri, Halla
    Fisher, George A.
    Longacre, Teri A.
    Suarez, Carlos J.
    Yao, James C.
    Kulke, Matthew H.
    Hendifar, Andrew Eugene
    Shanks, James Christopher
    Shah, Manisha H.
    Zalupski, Mark
    Schmulbach, Edmond L.
    Reidy, Diane Lauren
    Strosberg, Jonathan R.
    O'Dwyer, Peter J.
    Benson, Al Bowen
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211).
    Kunz, Pamela L.
    Catalano, Paul J.
    Nimeiri, Halla Sayed
    Fisher, George A.
    Longacre, Teri A.
    Schrijver, Iris
    Reidy, Diane Lauren
    Strosberg, Jonathan R.
    O'Dwyer, Peter J.
    Benson, Al Bowen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] A Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors: ATrial of the ECOG-ACRIN Cancer Research Group (E2211)
    Kunz, Pamela L.
    Catalano, Paul
    Nimeiri, Halla S.
    Fisher, George A., Jr.
    Longacre, Teri A.
    Suarez, Carlos J.
    Yao, James C.
    Kulke, Matthew H.
    Hendifar, Andrew
    Shanks, James C.
    Shah, Manisha H.
    Zalupski, Mark M.
    Schmulbach, Edmond
    Reidy-Lagunes, Diane L.
    Strosberg, Jonathan R.
    O'Dwyer, Peter J.
    Benson, Al B.
    PANCREAS, 2019, 48 (03) : 443 - 443
  • [5] Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 Study
    Owonikoko, Taofeek K.
    Dahlberg, Suzanne E.
    Sica, Gabriel L.
    Wagner, Lynne, I
    Wade, James L., III
    Srkalovic, Gordan
    Lash, Bradley W.
    Leach, Joseph W.
    Leal, Ticiana B.
    Aggarwal, Charu
    Ramalingam, Suresh S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (03) : 222 - +
  • [6] A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511)
    Owonikoko, Taofeek K.
    Dahlberg, Suzanne E.
    Khan, Saad A.
    Gerber, David E.
    Dowell, Jonathan
    Moss, Rebecca A.
    Belani, Chandra P.
    Hann, Christine L.
    Aggarwal, Charu
    Ramalingam, Suresh S.
    LUNG CANCER, 2015, 89 (01) : 66 - 70
  • [7] A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: A trial of the ECOG-ACRIN Cancer Research Group (EA2174).
    Eads, Jennifer Rachel
    Weitz, Michelle
    Gibson, Michael K.
    Rajdev, Lakshmi
    Khullar, Onkar, V
    Lin, Steven H.
    Gatsonis, Constantine
    Wistuba, Ignacio Ivan
    Sanjeevaiah, Aravind
    Benson, Al Bowen
    Bahary, Nathan
    Spencer, Kristen Renee
    Saba, Nabil F.
    Hamilton, Stanley R.
    Staley, Charles A.
    Chakravarthy, Anuradha Bapsi
    Wong, Terence Z.
    O'Dwyer, Peter J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E3508)
    Argiris, A.
    Lee, J. W.
    Stevenson, J.
    Sulecki, M. G.
    Hugec, V.
    Choong, N. W.
    Saltzman, J. N.
    Song, W.
    Hansen, R. M.
    Evans, T. L.
    Ramalingam, S. S.
    Schiller, J. H.
    ANNALS OF ONCOLOGY, 2017, 28 (12) : 3037 - 3043
  • [9] Randomized phase II clinical trial of cisplatin/carboplatin and etoposide (CE) alone or in combination with nivolumab as frontline therapy for extensive-stage small cell lung cancer (ES-SCLC): ECOG-ACRIN EA5161.
    Leal, Ticiana
    Wang, Yating
    Dowlati, Afshin
    Lewis, DeQuincy Andrew
    Chen, Yuanbin
    Mohindra, Amit Ramesh
    Razaq, Mohammad
    Ahuja, Harish G.
    Liu, Jijun
    King, David M.
    Sumey, Christopher Joseph
    Ramalingam, Suresh S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Randomized phase II study of gemcitabine plus cisplatin versus etoposide plus cisplatin for the treatment of locally advanced or metastatic non-small cell lung cancer: Korean Cancer Study Group experience
    Kim, JH
    Kim, SY
    Jung, KH
    Park, K
    Suh, CW
    Lim, HY
    Kim, YH
    Ryoo, BY
    Cho, EK
    Park, BJ
    Heo, DS
    LUNG CANCER, 2006, 52 (01) : 75 - 81
12345